Literature DB >> 20576616

Deciphering the kinetic binding mechanism of dimeric ligands using a potent plasma-stable dimeric inhibitor of postsynaptic density protein-95 as an example.

Celestine N Chi1, Anders Bach, Marie Gottschalk, Anders S Kristensen, Kristian Strømgaard, Per Jemth.   

Abstract

Dimeric ligands can be potent inhibitors of protein-protein or enzyme-substrate interactions. They have increased affinity and specificity toward their targets due to their ability to bind two binding sites simultaneously and are therefore attractive in drug design. However, few studies have addressed the kinetic mechanism of interaction of such bivalent ligands. We have investigated the binding interaction of a recently identified potent plasma-stable dimeric pentapeptide and PDZ1-2 of postsynaptic density protein-95 (PSD-95) using protein engineering in combination with fluorescence polarization, isothermal titration calorimetry, and stopped-flow fluorimetry. We demonstrate that binding occurs via a two-step process, where an initial binding to either one of the two PDZ domains is followed by an intramolecular step, which produces the bidentate complex. We have determined all rate constants involved in the binding reaction and found evidence for a conformational transition of the complex. Our data demonstrate the importance of a slow dissociation for a successful dimeric ligand but also highlight the possibility of optimizing the intramolecular association rate. The results may therefore aid the design of dimeric inhibitors in general.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20576616      PMCID: PMC2934690          DOI: 10.1074/jbc.M110.124040

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

Review 1.  Design and discovery of protein dimerizers.

Authors:  P A Clemons
Journal:  Curr Opin Chem Biol       Date:  1999-02       Impact factor: 8.822

2.  The affinity-enhancing roles of flexible linkers in two-domain DNA-binding proteins.

Authors:  H X Zhou
Journal:  Biochemistry       Date:  2001-12-18       Impact factor: 3.162

3.  Unexpected modes of PDZ domain scaffolding revealed by structure of nNOS-syntrophin complex.

Authors:  B J Hillier; K S Christopherson; K E Prehoda; D S Bredt; W A Lim
Journal:  Science       Date:  1999-04-30       Impact factor: 47.728

4.  Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions.

Authors:  Michelle Aarts; Yitao Liu; Lidong Liu; Shintaro Besshoh; Mark Arundine; James W Gurd; Yu-Tian Wang; Michael W Salter; Michael Tymianski
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

Review 5.  Quantitative account of the enhanced affinity of two linked scFvs specific for different epitopes on the same antigen.

Authors:  Huan-Xiang Zhou
Journal:  J Mol Biol       Date:  2003-05-23       Impact factor: 5.469

Review 6.  The glutamate receptor ion channels.

Authors:  R Dingledine; K Borges; D Bowie; S F Traynelis
Journal:  Pharmacol Rev       Date:  1999-03       Impact factor: 25.468

Review 7.  Pegylation: a novel process for modifying pharmacokinetics.

Authors:  J M Harris; N E Martin; M Modi
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

8.  Selectivity and promiscuity of the first and second PDZ domains of PSD-95 and synapse-associated protein 102.

Authors:  Indra Adi Lim; Duane D Hall; Johannes W Hell
Journal:  J Biol Chem       Date:  2002-04-05       Impact factor: 5.157

9.  Supramodular structure and synergistic target binding of the N-terminal tandem PDZ domains of PSD-95.

Authors:  Jia-Fu Long; Hidehito Tochio; Ping Wang; Jing-Song Fan; Carlo Sala; Martin Niethammer; Morgan Sheng; Mingjie Zhang
Journal:  J Mol Biol       Date:  2003-03-14       Impact factor: 5.469

Review 10.  Mechanism and role of PDZ domains in signaling complex assembly.

Authors:  B Z Harris; W A Lim
Journal:  J Cell Sci       Date:  2001-09       Impact factor: 5.285

View more
  15 in total

1.  A high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1-2 and protects against ischemic brain damage.

Authors:  Anders Bach; Bettina H Clausen; Magda Møller; Bente Vestergaard; Celestine N Chi; Adam Round; Pernille L Sørensen; Klaus B Nissen; Jette S Kastrup; Michael Gajhede; Per Jemth; Anders S Kristensen; Patrik Lundström; Kate L Lambertsen; Kristian Strømgaard
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-17       Impact factor: 11.205

2.  Biophysical characterization of the complex between human papillomavirus E6 protein and synapse-associated protein 97.

Authors:  Celestine N Chi; Anders Bach; Åke Engström; Kristian Strømgaard; Patrik Lundström; Neil Ferguson; Per Jemth
Journal:  J Biol Chem       Date:  2010-11-27       Impact factor: 5.157

Review 3.  Analytical methods for kinetic studies of biological interactions: A review.

Authors:  Xiwei Zheng; Cong Bi; Zhao Li; Maria Podariu; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2015-01-27       Impact factor: 3.935

4.  Reconstitution of multivalent PDZ domain binding to the scaffold protein PSD-95 reveals ternary-complex specificity of combinatorial inhibition.

Authors:  James J McCann; Ucheor B Choi; Mark E Bowen
Journal:  Structure       Date:  2014-09-11       Impact factor: 5.006

5.  Targeting protein-protein interactions with trimeric ligands: high affinity inhibitors of the MAGUK protein family.

Authors:  Klaus B Nissen; Linda M Haugaard-Kedström; Theis S Wilbek; Line S Nielsen; Emma Åberg; Anders S Kristensen; Anders Bach; Per Jemth; Kristian Strømgaard
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

6.  Design of a PDZbody, a bivalent binder of the E6 protein from human papillomavirus.

Authors:  O Andreas Karlsson; Juan Ramirez; Daniel Öberg; Tony Malmqvist; Åke Engström; Maria Friberg; Celestine N Chi; Mikael Widersten; Gilles Travé; Mikael T I Nilsson; Per Jemth
Journal:  Sci Rep       Date:  2015-03-23       Impact factor: 4.379

7.  Unlocking latent kinetic information from label-free binding.

Authors:  John G Quinn; Micah Steffek; John M Bruning; Alexandra Frommlet; Melinda M Mulvihill
Journal:  Sci Rep       Date:  2019-12-05       Impact factor: 4.379

8.  A high-affinity, bivalent PDZ domain inhibitor complexes PICK1 to alleviate neuropathic pain.

Authors:  Nikolaj R Christensen; Marta De Luca; Michael B Lever; Mette Richner; Astrid B Hansen; Gith Noes-Holt; Kathrine L Jensen; Mette Rathje; Dennis Bo Jensen; Simon Erlendsson; Christian Ro Bartling; Ina Ammendrup-Johnsen; Sofie E Pedersen; Michèle Schönauer; Klaus B Nissen; Søren R Midtgaard; Kaare Teilum; Lise Arleth; Andreas T Sørensen; Anders Bach; Kristian Strømgaard; Claire F Meehan; Christian B Vaegter; Ulrik Gether; Kenneth L Madsen
Journal:  EMBO Mol Med       Date:  2020-04-30       Impact factor: 12.137

9.  PDZ domain-mediated interactions of G protein-coupled receptors with postsynaptic density protein 95: quantitative characterization of interactions.

Authors:  Thor C Møller; Volker F Wirth; Nina I Roberts; Julia Bender; Anders Bach; Birgitte P S Jacky; Kristian Strømgaard; Jan M Deussing; Thue W Schwartz; Karen L Martinez
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

Review 10.  Plasticity of PDZ domains in ligand recognition and signaling.

Authors:  Ylva Ivarsson
Journal:  FEBS Lett       Date:  2012-04-21       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.